Shelton Capital Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,702
Closed -$221K 847
2018
Q4
$221K Hold
6,702
0.02% 649
2018
Q3
$313K Hold
6,702
0.02% 565
2018
Q2
$290K Buy
6,702
+2,119
+46% +$102K 0.02% 586
2018
Q1
$255K Hold
4,583
0.02% 646
2017
Q4
$245K Buy
+4,583
New +$216K 0.02% 701
2017
Q3
Sell
-7,011
Closed -$423K 858
2017
Q2
$423K Hold
7,011
0.03% 416
2017
Q1
$486K Buy
7,011
+1,677
+31% +$116K 0.03% 380
2016
Q4
$356K Buy
+5,334
New +$347K 0.03% 532
2016
Q3
Sell
-9,620
Closed -$697K 821
2016
Q2
$697K Hold
9,620
0.06% 281
2016
Q1
$622K Hold
9,620
0.06% 304
2015
Q4
$689K Hold
9,620
0.07% 251
2015
Q3
$739K Hold
9,620
0.08% 230
2015
Q2
$713K Hold
9,620
0.07% 254
2015
Q1
$698K Sell
9,620
-714
-7% -$49.6K 0.08% 270
2014
Q4
$683K Sell
10,334
-730
-7% -$44.6K 0.08% 257
2014
Q3
$607K Hold
11,064
0.08% 271
2014
Q2
$643K Hold
11,064
0.09% 256
2014
Q1
$686K Hold
11,064
0.1% 215
2013
Q4
$591K Hold
11,064
0.09% 248
2013
Q3
$555K Hold
11,064
0.09% 246
2013
Q2
$507K Buy
+11,064
New +$495K 0.09% 250

Other funds holding MD

Shelton Capital Management's MD Position: Q1 2019 in Review

Shelton Capital Management sold out of Pediatrix Medical (MD) in Q1 2019, closing a stake of 6,702 shares — an estimated $221K sold.

Shelton Capital Management first reported a position in MD in Q2 2013 and held it in 21 quarters. The position peaked at $739K in Q3 2015. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

  • Shelton Capital Management reported no remaining Pediatrix Medical position as of Q1 2019 after selling out during the quarter.
  • Shelton Capital Management sold 6,702 Pediatrix Medical shares in Q1 2019, an estimated $221K.
  • Shelton Capital Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 21 quarters.
  • Shelton Capital Management's Pediatrix Medical position peaked at $739K in Q3 2015.
  • 297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on Shelton Capital Management's 13F filing for Q1 2019, filed 10 May 2019.